The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress | Zendy

Henry F. Chambers | Zendy; H. R. Cross | Zendy; Scott Evans | Zendy; Barry N. Kreiswirth | Zendy; Vance G. Fowler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress

Author(s) -

Henry F. Chambers,

H. R. Cross,

Scott Evans,

Barry N. Kreiswirth,

Vance G. Fowler

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw824

Subject(s) - medicine , resistance (ecology) , work (physics) , public health , public relations , political science , nursing , engineering , mechanical engineering , ecology , biology

The Antibacterial Resistance Leadership Group (ARLG), with funding from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, was created in June 2013. Its mission is to develop, prioritize, and implement a clinical research agenda that addresses the public health threat of antibacterial resistance. This article reports on the progress that the ARLG has made to date in fulfilling its mission. Since inception, the ARLG has received and reviewed >70 study proposals, initiated >30 studies, executed >300 agreements, included data from >7000 subjects, published >45 manuscripts, and provided opportunities for 26 mentees. Despite this substantial progress, there remains significant work to be accomplished. This article also describes the considerable challenges that lie ahead.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research